Author: Sutun Nayak

  • ACTIZEET Shilajit: Your Ideal Yoga Partner for Strength & Focus Post International Yoga Day

    ACTIZEET Shilajit: Your Ideal Yoga Partner for Strength & Focus Post International Yoga Day

    Kolkata (West Bengal) [India], June 17:  As International Yoga Day passes with millions embracing their mats and breath, a quiet reflection begins among serious practitioners: How can I deepen my practice beyond this one day? In the heart of this reflection stands ACTIZEET Shilajit — a powerful, natural ally that is fast becoming recognized as the best Shilajit for yoga.

    While yoga has become a global movement, rooted in India’s timeless spiritual heritage, sustaining a long-term, transformative yoga practice requires more than just discipline. Flexibility, stamina, and mental clarity—these are the pillars that define a meaningful yogic journey. ACTIZEET Shilajit, harvested from the pristine heights of the Indian Himalayas, steps forward as the perfect complement to every yogi’s pursuit.

    A Timely Reflection: Beyond International Yoga Day

    International Yoga Day on June 21st inspires millions to pause, breathe, and reconnect with their inner selves. Yet, for many, this day also serves as a reminder of the physical and mental demands that come with a consistent yoga routine. Joint stiffness, fatigue, and mental fog often challenge even the most dedicated practitioners.

    ACTIZEET Shilajit offers a time-tested solution. “Yoga is not only a physical art but also a science of energy, breath, and focus,” shares Tapas K. Biswas, Founder of ACTIZEET. “ACTIZEET Shilajit naturally supports these elements, helping yogis to move beyond surface-level practice into deeper, sustained transformation.”

    Why ACTIZEET Shilajit is the Best Shilajit for Yoga

    ACTIZEET sources its Shilajit directly from untouched Himalayan rock formations, carefully purifying it to retain maximum potency. Unlike many commercial products, ACTIZEET offers 100% pure, resin-form Shilajit — a rare adaptogen rich in fulvic acid, trace minerals, and bioactive nutrients that work synergistically to support the yogic body and mind.

    Here’s why ACTIZEET Shilajit stands out as the best Shilajit for yoga:

    • Enhanced Flexibility: Shilajit’s anti-inflammatory properties help reduce joint stiffness and muscular tension, enabling smoother transitions and deeper stretches during asanas.

    • Sustained Energy & Stamina: Shilajit optimizes mitochondrial function, supporting consistent, sustainable energy without spikes or crashes — perfect for extended yoga sessions or multi-day retreats.

    • Sharper Mental Clarity: With neuroprotective benefits, ACTIZEET Shilajit enhances concentration, aiding in breath control, meditation, and mindfulness—cornerstones of yogic practice.

    • Faster Recovery: Yoga challenges muscles in unique ways. Shilajit’s rich mineral content accelerates recovery, reduces soreness, and promotes cellular repair.

    • Hormonal Balance: Its adaptogenic nature helps stabilize hormonal levels, supporting mood regulation, reducing anxiety, and promoting emotional balance—essential for those committed to holistic wellness.

      ACTIZEET

    Rooted in Ancient Ayurveda, Validated by Modern Science

    Long revered as the “destroyer of weakness” in ancient Ayurvedic texts, Shilajit’s powers are not mythical but deeply rooted in science. Modern studies confirm its wide-ranging benefits—from reducing oxidative stress and inflammation to improving physical performance and cognitive function.

    “ACTIZEET Shilajit serves as a bridge between the ancient yogic wisdom and modern wellness science,” Biswas explains. “We are not just offering a supplement; we are honoring an ancient tradition while ensuring world-class purity and safety.”

    A Global Wellness Movement with Indian Roots

    As yoga continues to expand its reach globally, India remains at its spiritual core. ACTIZEET is proud to contribute to India’s global leadership in holistic health by offering products that are ethically sourced, sustainably harvested, and rigorously tested for purity.

    Every batch of ACTIZEET Shilajit undergoes stringent quality checks to ensure it is free from heavy metals, toxins, and contaminants. This dedication to purity makes ACTIZEET a trusted name among yoga instructors, practitioners, and wellness experts worldwide.

    The Ideal Post-Yoga Day Addition

    In the days following International Yoga Day, many seek ways to sustain their newfound inspiration. ACTIZEET Shilajit provides a simple yet powerful daily ritual — a pea-sized portion dissolved in warm water or milk can support yogis before or after practice, enhancing both performance and recovery.

    For those serious about their yoga journey, ACTIZEET Shilajit becomes more than just a supplement — it becomes a companion, supporting the body’s subtle energies, physical resilience, and mental calm.

    Now Available: ACTIZEET Shilajit

    ACTIZEET  Original Shilajit is available for direct purchase through the brand’s official website, with delivery available across India and select international markets. As more practitioners seek authentic support for their yoga journey, ACTIZEET remains committed to offering the best Shilajit for yoga — pure, potent, and deeply rooted in India’s wellness heritage.

    About ACTIZEET

    ACTIZEET is India’s trusted herbal wellness brand, offering pure, ethically sourced, and scientifically validated products rooted in Ayurveda. With a mission to preserve nature’s original strength, ACTIZEET delivers unmatched quality while empowering individuals to live healthier, more balanced lives.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • Dr. Arpit Chopra Jain Honored at United Nations Headquarters in New York

    Dr. Arpit Chopra Jain Honored at United Nations Headquarters in New York

    New Delhi [India], June 17: Dr. Arpit Chopra Jain, a distinguished figure in the field of alternative medicine, was invited as the Guest of Honour at the prestigious United Nations Global Excellence Awards held at the United Nations Headquarters in New York, USA. The grand event, organized by the United Nations Global Peace Council, took place on June 9, 2025, at the renowned Martinique New York on Broadway hotel.
    In addition to this honor, Dr. Jain was also recognized at the International Peace Conclave for his remarkable contributions toward health, societal development, international peace, and global cooperation. He was presented with a Certificate of Appreciation, officially signed and awarded by a United Nations Correspondent & Global Affairs Analyst.
    This international recognition of Dr. Arpit Chopra Jain’s extraordinary work and dedication marks a proud moment for India and brings a new level of global acknowledgement to the Indian system of alternative medicine. His achievements serve not only the medical community but also elevate India’s reputation on the world stage.
    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
  • ENBEE Trade and Finance may declare up to 50% interim dividend for FY 2025–26

    ENBEE Trade and Finance may declare up to 50% interim dividend for FY 2025–26

    • Company has recently entered in strategic alliance with Sunrise FinServe Pvt Ltd to boost loan disbursement efficiently

    • Partnership to enhance financial inclusion and streamline loan processing across Maharashtra and Gujarat and improve operational efficiency.

    Mumbai (Maharashtra) [India], June 17: ENBEE Trade and Finance Limited (BSE: 512441), a non-banking financial company is considering the declaration of upto 50% Interim Dividend for the Financial Year 2025- 26. Meeting of the Board of Directors of the company is scheduled on 20th June 2025 for the decision. Face value of the company’s share is Rs. 1 per share.

    For the financial year ended March 31, 2025, ENBEE Trade and Finance Ltd reported total revenue of Rs. 19.73 crore, a sharp increase from Rs.10.25 crore in FY 2023-24—translating to more than a 92% year-on-year growth. The company’s net profit for FY25 stood at Rs. 4.95 crore, reflecting a nearly 217% Y-o-Y rise compared to Rs. 1.56 crore in FY24. For the fourth quarter that ended on March 31, 2025, the company recorded a consolidated net profit of Rs. 1.64 crore, a 76% Y-o-Y rise compared to net profit of Rs.0.93 crore in Q4 FY24. These results underscore ENBEE’s strong operational momentum, robust growth strategy, and disciplined financial execution.

    Company has recently announced a strategic alliance with Sunrise FinServe Pvt Ltd in a move aimed at significantly enhancing the efficiency and scalability of its loan disbursement operations. The partnership marks a an important step in ENBEE’s ongoing efforts to strengthen its lending ecosystem, particularly across the states of Maharashtra and Gujarat.

    This collaboration will see ENBEE leveraging Sunrise FinServe’s experience, strong distribution network, and advanced customer acquisition capabilities to enhance the lending processes. The partnership is set up to speed things up, make the application process easier, and help more people in smaller towns and underserved areas get access to credit.

    The management of ENBEE Trade and Finance Ltd, commented, “We’re really happy to team up with Sunrise FinServe Pvt Ltd as we grow our lending business. This partnership will help us work more smoothly and reach more people who need financial support. With Sunrise’s experience and strong digital network, we’ll be able to offer faster and easier financial services, especially in important areas like Maharashtra and Gujarat.”

    Enbee Trade & Finance has taken an aggressive stance on sustainable finance, targeting projects in solar panel installations, wind energy developments, Electric Vehicle (EV) charging infrastructure.

    Additionally, the company plans to fund startups promoting green technologies and enterprises aligned with ESG standards. This includes financial backing for renewable energy adoption, social impact ventures and eco-friendly industry practices.

    The company came up with Rs 45.08 crore Right Issue in December 2024. The issue size was 3,46,76,061 shares. The Rights Issue was priced at ₹13 per share, offered existing shareholders an opportunity to enhance their equity stake in the company. The Board of Directors had considered and approved the rights issue, with an entitlement of 121 Rights Equity Shares for every 50 fully paid-up equity shares held as on the record date of November 28, 2024. Enbee Trade and Finance Rights Issue 2024 got oversubscribed by 1.03 times by the end of the bidding period with total bid quantity received by BSE of 3,55,58,889 shares. The amount was raised to repay unsecured loans availed by the company from promoter and promoter group of the company as well as augmentation of capital base of the company.

     About ENBEE Trade and Finance Limited

    Established in 1985, ENBEE Trade and Finance Ltd is a non-deposit taking NBFC registered with the Reserve Bank of India. The company is primarily engaged in providing business loans, personal loans, and structured financial solutions to SMEs and individuals.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Sidhant Singh: Actor and Entrepreneur Driving Growth On and Off Screen

    Sidhant Singh: Actor and Entrepreneur Driving Growth On and Off Screen

    Mumbai (Maharashtra) [India], June 17: Bollywood actor and entrepreneur Sidhant Singh is building a legacy that bridges cinema, industry, and rural empowerment — with an eye on global growth.

    An MBA graduate from the Indian Institute of Planning and Management (IIPM), Sidhant later trained at the prestigious Barry John Acting Studio, refining his craft as a performer. He further enhanced his business knowledge by completing a course from the Indian International Trade Centre (IITC), equipping him with insights into international trade and exports — a skill now powering his mission to take Indian rice and poha to global markets.

    Sidhant made his acting debut in the comedy-thriller Hume Toh Loot Liya, sharing screen space with popular names such as Rajpal Yadav, Sanjay Mishra, Manoj Joshi, Sharat Saxena, Tinnu Anand, Vijay Patkar, Upasana Singh, and Mustaq Khan. In addition, he has appeared in music video singles, growing his digital presence steadily.

    Outside of entertainment, Sidhant comes from a strong construction background, with real estate developments in Mumbai and Palghar. His family is now introducing a “second home” concept in Palghar district — creating modern residential retreats for city dwellers seeking nature, peace, and comfort.

    In the agri-industry space, Sidhant is launching Maharashtra’s largest rice and poha processing plant in Urse village, Dist Palghar, under his brand Nana Nani Foods. The high-capacity facility — processing 9 tons per hour combined— is focused on empowering farmers, supporting local economies, and establishing strong export channels for Indian grains.

    Sidhant is also exploring vertical-format web series through his production house Toronto Media, aiming to engage India’s fast-growing mobile-first audience with smartphone-optimized entertainment. Shoot begins soon

    “Building a legacy means creating impact in every field you touch.”

    — Sidhant Singh

    From acting and agro-industry to global exports and digital storytelling, Sidhant Singh’s journey reflects a powerful blend of vision, versatility, and value creation — on and off screen.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • String Metaverse (BSE: META) Secures Canadian Fintech License, Rebrands to String Payx

    String Metaverse (BSE: META) Secures Canadian Fintech License, Rebrands to String Payx

    Hyderabad (Telangana) [India], June 17: InString Metaverse Limited (BSE: META), a next-generation digital finance infrastructure Web3  company, is pleased to announce that it has officially received its Fintech License (MSB registration) from FINTRAC Canada, headquartered in Vancouver. In alignment with this significant milestone, the Canadian company will undergo a strategic rebranding to String Payx, with the name change to be reflected across all regulatory and operational platforms within the next 60 days.

    This license marks a pivotal expansion for String Metaverse, empowering it to launch comprehensive Web3-enabled digital banking services, including:

    • Issuance of Virtual Debit Cards
    • Cross-Border Wire Transfers
    • Full-suite Payment Solutions for businesses and individuals
    • Virtual Corporate Accounts
    • Seamless Crypto-to-Fiat On-Ramp and Off-Ramp capabilities

    String Metaverse is uniquely positioned at the convergence of gaming, digital assets, and fintech. With an existing user base of 4 million gamers, projected to reach 10 million, the company will leverage this license to issue Virtual Visa and Mastercard Debit Cards, fully integrated with Apple Pay and Google Pay. This enables instant global payments at over 170 million merchants across both physical and digital platforms.

    “This license is a game-changer,” said [CEO  Santosh Althuru], CEO of String Metaverse. “It enables us to power the next wave of financial services for Web3-native users, seamlessly merging crypto, gaming, and global payments.”

    This development is aligned with String’s mission to build the public infrastructure layer for open, yield-bearing financial ecosystems on blockchain — where stablecoins, tokenized assets, and real-world payments converge.

    About String Metaverse first Web3.0 company listed on Indian exchanges (BSE: META), is building the Internet Financial System of the future. The company’s infrastructure powers scalable digital banking, payment rails, and asset tokenization, connecting Web3 innovation with real-world utility across borders.

    Disclaimer: Trading cryptocurrencies carries a high level of risk, and may not be suitable for all investors. You should be aware of all the risks associated with cryptocurrency trading, and seek advice from an independent financial advisor. Any opinions, news, research, analyses, prices, or other information contained on this website is provided as general market commentary, and does not constitute investment advice. The website or its publishers will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information.

  • Narayana’s Legacy of Excellence Continues with NEET 2025 Top Ranks

    Narayana’s Legacy of Excellence Continues with NEET 2025 Top Ranks

    New Delhi [India], June 16:  The institution proudly celebrates the achievements of Mrinal Kishore Jha (Delhi)(AIR4), Keshav Mittal (Punjab) (AIR7), Aashi Singh (Delhi) (AIR12), Soumya Sharma (Rajasthan)(AIR14), Kakarla Jeevan Sai Kumar (Telangana) (AIR18), and Rupyan Pal (West Bengal) ( AIR20).

    With 21 positions in the Top 100 and 84 in the Top 1000, Narayana has once again demonstrated its leadership in NEET coaching. Jeevan Sai Kumar also brought special recognition by topping both Telugu-speaking states.

    https://www.youtube.com/watch?v=yoDJyQ-REiI

    With a legacy of over 46 years, Narayana Educational Institutions have consistently set benchmarks in major national-level competitive exams like NEET, JEE, UPSC, and Olympiads. These stellar results are the outcome of a meticulously designed academic system, combining conceptual clarity, systematic practice tests, expert faculty, tech-driven learning frameworks, and Disha, a specialised programme focused on students’ mental well-being.

    Congratulating the achievers, Dr. P. Sindhura Narayana, Director of Narayana Educational Institutions, said, “NEET-UG is among India’s toughest exams, with over 22 lakh students competing for limited seats in top medical colleges. At Narayana, we focus on building strong concepts, sharpening problem-solving abilities, and driving constant improvement through structured evaluation and personalised feedback. Our micro-schedules, crafted by the R&D team, help students optimise their preparation and systematically cover every crucial topic. Continuous error analysis and tailored mentoring further refine their readiness for competitive exams like NEET.”

    Key Points:

    • Narayana Educational Institutions continues their stellar record of academic success in NEET-UG 2025 with All India Ranks 4, 7, 12, 14, 18, 20, and 35 in the open category.

    Ms. P. Sharani Naryana, Director of Narayana Educational Institutions, credited the exceptional results to the combined efforts of students, teachers, and parents. She highlighted the pivotal role of technology in this achievement, stating, “Through our proprietary Online self-learning app, nLearn, teachers monitor individual student progress in real-time, providing targeted support whenever required. The platform’s comprehensive tests enable students to benchmark themselves and identify areas of improvement. The dedication and perseverance of our students, supported by these robust systems, have once again brought laurels to Narayana, reaffirming our position as a leading institution for medical aspirants.”

    With decades of educational excellence, Narayana continues to redefine success in competitive exams, guiding countless students toward fulfilling their dreams, because at Narayana, ‘Your Dreams Are Our Dreams’

    About Narayana Educational Institutions

    With a vast network of 900+ schools, colleges, coaching centers, and professional colleges across 23 Indian states and 250+ cities, Narayana Educational Institutions is one of Asia’s largest and well-respected education groups with over 46 years of legacy in the field of education. The institution has a team of more than 50,000+ highly experienced teachers, R&D Heads, and Subject Matter Experts, in addition to the non-academic staff, who help over 600,000+ students every year with their education, from kindergarten to post-graduate studies. Their central focus remains on striking a harmonious balance between the curricular and co-curricular domains so that the students reach their full potential. Furthermore, they offer comprehensive academic programmes tailored to help students realize their ambitions in the engineering, medical, CA, and civil service streams, showcasing their firm dedication to career-oriented teaching. With this, Narayana commits to fulfilling dreams of millions across the nation as at Narayana, your dreams are our dreams.

    To know more, visit us at: https://www.narayanaschools.in/

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • Indore to Host 7-Day Sickle Cell Awareness Campaign (June 13-20) Ahead of World Sickle Cell Day

    Indore to Host 7-Day Sickle Cell Awareness Campaign (June 13-20) Ahead of World Sickle Cell Day

    Indore (Madhya Pradesh) [India], June 17:  World Sickle Cell Day will be observed on June 19. Marking the occasion, a special seven-day awareness campaign on sickle cell disease will be held across Indore city and the surrounding rural areas. The initiative is being jointly organised by Sansad Seva Prakalp and the Advanced Homoeopathic Medical Research and Welfare Society, Indore, under the theme “An Aware Step Towards a Healthy Life.” The campaign will run from  13th  to 20th  June 2025
    The main objective of this drive is to raise public awareness about the dangerous genetic disorder, sickle cell disease, and promote early detection and prevention. Various awareness programs will be conducted under the leadership of Indore MP Shankar Lalwani and homoeopathy expert Dr. A.K. Dwivedi.
    Free blood testing camps will be organised in urban and rural areas, with a focus on educating people about the importance of haemoglobin electrophoresis tests. Activities like street plays, distribution of pamphlets and booklets, poster exhibitions, and interactive sessions will also be held as part of the campaign.
    What is Sickle Cell Disease?
    Dr. AK Dwivedi explained that sickle cell disease is a hereditary blood disorder in which red blood cells become crescent or sickle-shaped, disrupting oxygen supply throughout the body. This can lead to symptoms like fatigue, intense pain, anaemia, bone issues, and organ damage. In some cases, it can even be fatal.
    He emphasized that with timely diagnosis and proper awareness, the disease can be controlled and prevented from being passed on to future generations. He added that awareness is not just a medical duty, but also a social responsibility. Dr. Dwivedi, who is a professor and head of department at a homeopathic medical college, is also a member of scientific Advisory Board,  Central Council for Research in Homeopathy (AYUSH Ministry, Govt. of India) and also  Executive Council Member of Devi Ahilya University, Indore. He regularly leads awareness drives on sickle cell and other serious conditions like aplastic anemia.
    “A New Beginning in Public Health Awareness”
    MP Shankar Lalwani said the awareness drive in Indore is in line with Prime Minister Narendra Modi’s vision for an “Anemia-Free India Mission 2047.” He added that the campaign would involve active community participation and mark a new beginning in public health awareness
    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
  • GNC India Unveils Protein Wafer: Crunchy, Munchy, and Packed with Protein

    GNC India Unveils Protein Wafer: Crunchy, Munchy, and Packed with Protein

    Mumbai (Maharashtra) [India], June 16: Guardian Healthcare Pvt. Ltd., the primary franchisee of GNC in India (“GNC India”), has announced the launch of the GNC Protein Wafer, a revolutionary protein-enriched snack that promises to transform how Indians satisfy their cravings. Combining mouth-watering taste with clean, functional nutrition, the Protein Wafer is designed for the modern-day consumer who refuses to choose between health and indulgence.

    The GNC Protein Wafer offers a convenient solution for fitness conscious customers on the move. Each pack delivers 10 grams of high-quality whey protein, and is free from sugar, trans-fats, and palm oil. This innovative offering blends taste, texture, and nutritional integrity into a snack that feels like a cheat but isn’t.

    Speaking on the launch, Balaji Uppala, CEO of GNC India, said, “Today’s Indian consumer is sharper, more aware, and seeking products that deliver real value, nutritionally and experientially. The GNC Protein Wafer is not just a snack, it’s our answer to the evolving lifestyle where protein is essential, but pleasure is non-negotiable. We have created a wafer that is both functional and fantastically craveable.”

    The GNC Protein Wafer supports muscle recovery and lean mass development, while also helping curb those sudden hunger pangs that usually lead to poor snacking choices. With zero sugar and no artificial fillers, it fits seamlessly into high-protein diets, fitness plans, or simply as a smarter everyday snack.

    Ashutosh Taparia, Managing Director and Board Member of Guardian Healthcare, commented, “Consumers no longer want boring nutrition. They’re asking for indulgence with intention, food that performs and delights. The GNC Protein Wafer brings that balance to the shelf—pure protein, rich flavors, clean labels, and total snack satisfaction.”

    The GNC Protein Wafer is now available in three indulgent flavor varieties, carefully crafted to appeal to a wide range of palates. The coffee flavor delivers a deep, roasted aroma paired with smooth creaminess. The chocolate version offers intense cocoa notes wrapped in a delicate crunch. The peanut butter flavor brings a bold, nutty richness that lingers delightfully.

    Find the GNC Protein Wafer on GNC India’s official website and in select retail stores nationwide, or on Amazon, Flipkart, Nykaa, and Hyugalife. The GNC Protein Wafer is poised to be the country’s next go-to snack for health-conscious millennials, gym-goers, working professionals, and anyone craving something deliciously functional.

    Backed by GNC’s commitment to innovation and quality, the Protein Wafer is redefining how India eats, trains, and indulges—proving that a snack can be both clean and delicious.

    For media inquiries, please contact:
    Tanya Sharma
    tanya.s@oneguardian.in | +91 99991 47699

    About GNC:

    GNC is a leading global health and wellness brand that provides customers with a wide variety of science-based products and solution services to live well. The brand touches consumers worldwide by providing its products and services through company-owned retail locations, domestic and international franchise locations, digital commerce, and strong wholesale and retail partnerships across the globe. GNC’s diversified, multi-channel business model has worldwide reach and a well-recognized, trusted brand. By combining exceptional innovation, product development capabilities, and an extensive global distribution network, GNC manages a best-in-class product portfolio.

    About Guardian Healthcare Private Limited:

    Guardian Healthcare Private Limited, is the master franchisee holder of GNC for India. Guardian Healthcare, with 60+ premium pharmacies across India, serves over 10 million customers. Offering 100% reliable health, wellness, and pharmaceutical products, Guardian Pharmacy prioritizes reliability, customer satisfaction, and trust.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

  • Freshara Agro Exports Achieves Rs. 260+ Cr Total Revenue in FY25, Setting a New Milestone

    Freshara Agro Exports Achieves Rs. 260+ Cr Total Revenue in FY25, Setting a New Milestone

    Chennai (Tamil Nadu) [India], June 16:  Freshara Agro Exports Limited specializes in procurement, processing, and exporting preserved gherkins and pickled vegetables, has released its audited financial results for H2 FY25.

    Key Financial highlights :

    In the second half of FY25 (H2 FY25), the company reported a total revenue of ₹15,322.11 lakhs, reflecting a robust 42.58% increase over the first half (H1 FY25), which stood at ₹10,746.11 lakhs. EBITDA also saw significant growth, rising 46.70% to ₹2,749.47 lakhs in H2 FY25 compared to ₹1,874.21 lakhs in H1 FY25. The EBITDA margin improved by 62.53 basis points, reaching 18.71% in H2 FY25, up from 18.08% in H1 FY25.

    Profit After Tax (PAT) increased sharply by 53.02%, amounting to ₹1,741.05 lakhs in H2 FY25 against ₹1,137.81 lakhs in the first half. Correspondingly, the PAT margin improved by 86.86 basis points, moving up to 11.85% from 10.98%. Earnings Per Share (EPS) also rose by 16.14%, from ₹6.69 in H1 FY25 to ₹7.77 in H2 FY25, indicating stronger shareholder returns.

    Business & Operations Highlights

    Financial Strength:

    Freshara holds ₹84 Crore in rated bank loan facilities and has maintained stable CRISIL ratings of BBB/Stable (long-term) and A3+ (short-term), reflecting a robust credit profile and supporting efficient financing for future growth.

    Expansion Milestone Achieved:
    Operationalized a state-of-the-art second manufacturing unit spread over 8 acres in Tirupattur District, Tamil Nadu, marking a major leap in production scale and operational efficiency.

    The company commenced commercial production on January 2, 2025, at its 2nd manufacturing plant located in Chengilikuppam Village, Tirupattur District.

    Enhanced Production Capacity:

    • Processing Capacity: 75–100 MT/day
    • Retail Packing: 6,000 jars/hour, scalable to 18,000 jars/hour
    • Open Yard Storage: 300,000 sq. ft. for increased raw material handling
    • Built-Up Area: 1,25,000 sq. ft. including warehousing and processing zones

     Sustainable Infrastructure:
    Commissioned a 100KW solar power plant, reinforcing Freshara’s commitment to energy efficiency and cost optimization.

    Product Portfolio Expansion:
    Added new high potential products such as Green Pepper Corns, Corn Kernels, Olives, and White Onions to meet rising global demand and consumer diversification.

    Advanced Packaging Capabilities:
    Broadened packaging formats across Industrial, Food Service, and Retail segments. Exploring vacuum packing and dehydration technologies for future deployment.

    Scalable Growth Outlook:
    This ₹35-40 Cr investment is projected to unlock ₹200–250 Cr in annual revenues at full capacity and drive 10–30% YoY growth, supported by volume expansion and margin enhancement.

    Operational Status:
    As of June 2025, the unit is 95% complete, with both industrial and retail production lines live and delivering initial outputs to global markets.

    Commenting on the performance, Mr. Junaid Ahmed, Managing Director and Chairman of Freshara Agro Exports Limited said “FY25 has been a remarkable year for Freshara, marked by strong growth and transformation. Despite global challenges, we remained focused and resilient. Our commitment to quality, sustainability, and operational excellence has strengthened our presence across international markets. As demand for clean-label and naturally preserved foods rises, Freshara is well positioned to lead with trusted products. Backed by a network of over 4,000 farmers, we take immense pride in building a brand that exemplifies the best of India’s agri-export strength on the world stage.

    Our H2 FY25 results reflect this progress, with a 42.58% increase in total revenue to ₹15,322.11 lakhs, compared to ₹10,746.11 lakhs in H1 FY25. EBITDA rose by 46.70% to ₹2,749.47 lakhs, up from ₹1,874.21 lakhs in the H1 FY25. PAT grew by 53.02% to ₹1,741.05 lakhs, compared to ₹1,137.81 lakhs in H1 FY25, underscoring our strong operational and financial discipline. The EBITDA margin increased to 18.71% from 18.08%, while the PAT margin improved to 11.85% from 10.98%, indicating enhanced efficiency.

    A cornerstone of this year’s achievements is the operational launch of our second world-class manufacturing facility. Spread across 8 acres, the facility supports both industrial and retail packaging with a daily capacity of 75–100 MT and packing of up to 18,000 jars per hour. This ₹30–35 crore investment allows us to expand our product range and adopt new packaging technologies. Backed by a 100KW solar plant, the unit is expected to drive 10–30% annual revenue growth and enhance margins through scale and efficiency.

    Our NSE Emerge listing in October 2024 was the beginning of a bold new chapter. With expanded capacity, deeper global reach, and a strong execution pipeline, Freshara is poised to lead with performance and purpose in the international agri-export space.

    Freshara Agro Exports Limited is a leading exporter of processed gherkins and other pickled vegetables, operating two state-of-the-art facilities in Tirupattur district of Tamil Nadu, with a strong global presence in 40+ countries, including Europe, the USA, and Russia. Freshara ensures the highest quality standards through certifications like IFS, BRCGS, FSSAI, FDA & Kosher. Supporting over 4,000 farmers, the company is committed to sustainability, and farmer empowerment. Recognized as a 100% Export Oriented Unit, Freshara has earned prestigious accolades for excellence in exports from its inception, including the FIEO MSME Exporter Awards for 2016-17, 2017-18, MEPZ Award for the Year 19-20, Tamil Nadu State MSME awards for the Year 2021-22 and the ASSOCHAM Awards for the years 2022-23, 2023-24, 2024-25.

    Freshara Agro Exports Limited was successfully listed on NSE Emerge on October 24th, 2024.

    In H2 FY25, Freshara Agro Exports Limited reported robust financial performance with a Total Revenue of ₹15,322.11 Lakhs, an EBITDA of ₹2,749.47 Lakhs, and a PAT of ₹1,741.05 Lakhs.

    In FY25, Freshara Agro Exports Limited Reported Total Revenue of ₹26,068.21 Lakhs, with an EBITDA of ₹4,581.88 Lakhs and a PAT of ₹2,878.86 Lakhs.

    Disclaimer

    Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • LANXESS starts fiscal year 2025 with significant earnings increase

    LANXESS starts fiscal year 2025 with significant earnings increase

    Mumbai (Maharashtra) [India], June 16: Specialty chemicals company LANXESS has started the 2025 fiscal year with a significant increase in earnings: EBITDA pre exceptionals rose by 31.7 percent from EUR 101 million to EUR 133 million, despite the weak global economic environment. The Group improved its earnings in all segments, mainly due to better capacity utilization and cost savings as part of the “FORWARD!” action plan.

    Sales in the first quarter remained stable at EUR 1.601 billion, on a par with the prior-year figure of EUR 1.607 billion. LANXESS increased sales volumes in most businesses, although lower sales prices had a negative impact on revenues.

    “We have made a solid start to the new fiscal year – despite all the adversities in the economic and geopolitical environment. Our more efficient positioning and improved cost situation are now paying off,” said Matthias Zachert, Chairman of the Board of Management of LANXESS AG. “The situation around us has continued to escalate since the beginning of the year. The U.S. government’s new trade policy has shaken the markets and exacerbated the already high level of uncertainty. Combined with the ongoing weakness of the economy, this makes the situation even more challenging for companies.”

    Net income for the first quarter of 2025 was minus EUR 57 million, compared with minus EUR 98 million in the same period last year.

    LANXESS confirms its guidance for the 2025 fiscal year and continues to expect EBITDA pre exceptionals of between EUR 600 and 650 million.

    For the second quarter of the fiscal year 2025, LANXESS anticipates an increase in earnings compared with the first quarter of 2025. However, compared with the same quarter of the previous year, the Group expects earnings to decline, primarily because the earnings contribution from Urethane Systems will no longer be included.

    Sale of the Urethane Systems business completed

    On 1 April 2025, LANXESS sold its Urethane Systems business to Japan’s UBE Corporation, thus divesting its last remaining polymer business. The transaction was the last major step in the company’s portfolio transformation towards specialty chemicals.

    LANXESS will use the proceeds from the sale to redeem its EUR 500 million benchmark bond due May 2025 and further reduce its debt.

    Business development in the segments

    The Consumer Protection segment posted first-quarter sales of EUR 513 million, an increase of 0.8 percent compared with the prior-year figure of EUR 509 million. EBITDA pre exceptionals rose by 49 percent from EUR 49 million in the prior-year quarter to EUR 73 million. This was mainly due to higher sales volumes and the associated improvement in capacity utilization. In addition, cost savings from the “FORWARD!” action plan had a positive impact on earnings and margins. The EBITDA margin pre exceptionals was 14.2 percent, compared with 9.6 percent in the same period of the previous year.

    In the first quarter of 2025, the Specialty Additives segment recorded sales of EUR 545 million, down 3.7 percent on the first quarter of 2024, when sales amounted to EUR 566 million. EBITDA pre exceptionals increased by 8.3 percent from EUR 48 million in the same quarter of the previous year to EUR 52 million. The cost savings from the “FORWARD!” action plan also had a positive impact on earnings and margins, along with a favorable product mix. The EBITDA margin pre exceptionals was 9.5 percent, up from 8.5 percent in the prior-year quarter.

    The Advanced Intermediates segment generated sales of EUR 476 million in the first quarter of 2025, up 2.4 percent from EUR 465 million in the year-ago period. EBITDA pre exceptionals reached EUR 40 million, up 8.1 percent from EUR 37 million in the prior-year period. Higher sales volumes and cost savings from the “FORWARD!” action plan had a particularly positive impact on earnings and margins. The EBITDA margin pre exceptionals was 8.4 percent, slightly above the margin of 8.0 percent recorded in the same quarter of the previous year.

    Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in stocks includes financial risks, and past performance is not indicative of future results. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.